SAM
REGN icon

Senzar Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Senzar Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-5,220
Closed -$1.8M – 12
2018
Q2 		$1.8M Sell
5,220
-56,500
-92% -$17.7M 5.2% 6
2018
Q1 		$21.3M Sell
61,720
-51,780
-46% -$18M 6.71% 3
2017
Q4 		$42.7M Buy
113,500
+36,200
+47% +$14.7M 10.89% 2
2017
Q3 		$34.6M Buy
+77,300
New +$36.8M 8.44% 3

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Senzar Asset Management's REGN Position: Q3 2018 in Review

Senzar Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2018, closing a stake of 5,220 shares — an estimated $1.8M sold.

Senzar Asset Management first reported a position in REGN in Q3 2017 and held it in 4 quarters. The position peaked at $42.7M in Q4 2017. 644 funds tracked by Wall St. Rank hold REGN as of Q3 2018.

  • Senzar Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Senzar Asset Management sold 5,220 Regeneron Pharmaceuticals shares in Q3 2018, an estimated $1.8M.
  • Senzar Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2017 and held it in 4 quarters.
  • Senzar Asset Management's Regeneron Pharmaceuticals position peaked at $42.7M in Q4 2017.
  • 644 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2018.

Based on Senzar Asset Management's 13F filing for Q3 2018.